Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
Clinical Validation of Predictive Procedural Planning Software in a Real-World TAVI Population.
СтатьяВалидационное исследованиеСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Claes Anne-Sophie, Paelinck Bernard, Rodrigus Inez, Vandendriessche Tom, Jardinet Thomas, De Roeck Frederic, Bosmans Johan, Van Herck Paul
Аннотация
BACKGROUND: Preprocedural virtual planning of transcatheter aortic valve implantation (TAVI) using FEops HEARTguideTM may reduce major TAVI complications.
AIMS: (1) To compare morphometric aortic root measurements by FEops HEARTguideTM and GE software; (2) to validate the accuracy of FEops HEARTguideTM in predicting post-TAVI paravalvular aortic regurgitation (AR) and new conduction abnormalities.
METHODS: In 106 consecutive TAVI patients, aortic root dimensions essential for prosthesis sizing were measured using both GE software and FEops HEARTguideTM. FEops HEARTguideTM predictions were compared with the severity of post-TAVI AR assessed by echocardiography, angiography, invasive hemodynamics, and the development of conduction abnormalities assessed by serial electrocardiography.
RESULTS: Bland-Altman analysis revealed smaller annulus perimeter, area and coronary artery ostia heights with FEops HEARTguideTM compared with GE software, leading to differences in prosthesis sizing in 23% of cases. Predicted AR was significantly higher in patients with moderate versus none/trace AR on echocardiography (14.3 vs. 2.8 mL/s, p = 0.006) and angiography (23.6 vs. 4.0 mL/s, p = 0.009), though overlap between adjacent AR grades was observed. Predicted AR did not significantly differ between patients with AR index < 25 and ≥ 25 (10.2 vs. 5.7 mL/s, p = 0.079). Contact pressure index was significantly higher in patients with new conduction abnormalities (17.5 vs. 10.0%, p = 0.006), despite overlap at patient level.
CONCLUSIONS: FEops HEARTguideTM generally underestimates aortic root dimensions compared with GE software, affecting prosthesis sizing in a substantial proportion of patients. While predictive at a population level, overlap in parameters predicted by FEops HEARTguideTM is encountered at an individual patient level.
AIMS: (1) To compare morphometric aortic root measurements by FEops HEARTguideTM and GE software; (2) to validate the accuracy of FEops HEARTguideTM in predicting post-TAVI paravalvular aortic regurgitation (AR) and new conduction abnormalities.
METHODS: In 106 consecutive TAVI patients, aortic root dimensions essential for prosthesis sizing were measured using both GE software and FEops HEARTguideTM. FEops HEARTguideTM predictions were compared with the severity of post-TAVI AR assessed by echocardiography, angiography, invasive hemodynamics, and the development of conduction abnormalities assessed by serial electrocardiography.
RESULTS: Bland-Altman analysis revealed smaller annulus perimeter, area and coronary artery ostia heights with FEops HEARTguideTM compared with GE software, leading to differences in prosthesis sizing in 23% of cases. Predicted AR was significantly higher in patients with moderate versus none/trace AR on echocardiography (14.3 vs. 2.8 mL/s, p = 0.006) and angiography (23.6 vs. 4.0 mL/s, p = 0.009), though overlap between adjacent AR grades was observed. Predicted AR did not significantly differ between patients with AR index < 25 and ≥ 25 (10.2 vs. 5.7 mL/s, p = 0.079). Contact pressure index was significantly higher in patients with new conduction abnormalities (17.5 vs. 10.0%, p = 0.006), despite overlap at patient level.
CONCLUSIONS: FEops HEARTguideTM generally underestimates aortic root dimensions compared with GE software, affecting prosthesis sizing in a substantial proportion of patients. While predictive at a population level, overlap in parameters predicted by FEops HEARTguideTM is encountered at an individual patient level.
Предметные рубрики MeSH
HumansMaleFemalePredictive Value of TestsAged, 80 and overAortic ValveAortic Valve InsufficiencyHeart Valve ProsthesisAgedTranscatheter Aortic Valve ReplacementAortic Valve StenosisTreatment OutcomeReproducibility of ResultsProsthesis DesignHemodynamicsSeverity of Illness IndexDecision Support TechniquesCardiac CatheterizationSoftwarePatient-Specific Modeling